⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Statins
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-03 — IL-21R blockade reduces inflammation and atherosclerosis in LDL receptor deficient mice.: cross-connection with il-21r-blockade: Residual inflammation on top of lipid control is the same gap statin trials have highlighted; IL-21R blockade targets that residual immune component in a mouse atherosclerosis model. (novelty: 3)
- 2026-06-09 — Real-world evidence on In-hospital statin use and mortality in geriatric patients.: Retrospective geriatric-ward cohort (patients ≥75): in-hospital statin use on day 2 was associated with ~50% lower adjusted odds of in-hospital all-cause mortality versus non-use, extending observational signal into acute hospital and primary-prevention frail-leaning settings. [human-observational] (novelty: 3)
- 2026-09-14 — #407 ‒ Preventing cardiovascular and Alzheimer’s disease: lowering LDL early, APOE4, and promising new therapies | Michael Davidson, M.D.: cross-connection with ldl-lowering-therapies: Davidson’s early-LDL-lowering thesis situates statins as one tool within a broader lifetime cumulative-exposure framing rather than a late-life risk-reduction drug. (novelty: 3)
- 2026-09-09 — Statin use is associated with improved frailty trajectories in people with HIV.: Italian HIV clinic cohort (observational, matched non-users): statin initiation for CV prevention was associated with improved frailty-index trajectories over time, with lipid items excluded from the FI to limit collider bias; secondary physical-function endpoints (gait speed, SPPB, grip strength) were null. [human-observational] (novelty: 3)
Open questions
Related
Contributing findings
Statin use is associated with improved frailty trajectories in people with HIV.
09-sep-2026
novelty 3
per-area 3
strengthens
Real-world evidence on In-hospital statin use and mortality in geriatric patients.
09-jun-2026
novelty 3
per-area 3
strengthens